Boston Scientific extends Tobin's tenure
Boston Scientific Corp., the Natick medical-device maker, said today that chief executive Jim Tobin (right) will be "extending his tenure" and staying on for the "foreseeable future."
The company also said that Fred Colen will become the president of its cardiac rhythm management, or CRM, group and that Paul LaViolette, chief operating officer, will be retiring.
Colen has been with Boston Scientific since 1999, most recently as executive vice president of operations and technology for the CRM group.
LaViolette joined the company in 1994, and he has been chief operating officer since 2005.
"I am very pleased to announce that Jim Tobin will be extending his tenure as president and chief executive officer of Boston Scientific," Pete Nicholas, the company's cofounder and chairman of the board, said in a statement. "Two years ago we announced a similar extension."
For additional Globe coverage of Boston Scientific, please click here.
(By Chris Reidy, Globe staff)
